What are the clinical features of Poikiloderma of Civatte?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Features of Poikiloderma of Civatte

Poikiloderma of Civatte is a benign, acquired condition presenting with the classic triad of cutaneous atrophy, telangiectasias, and mottled pigmentary changes (both hyper- and hypopigmentation) affecting the lateral neck and upper chest, characteristically sparing the submental area. 1, 2

Patient Demographics and Distribution

  • Predominantly affects middle-aged to elderly women (67.86% female in dermoscopy studies), particularly those who are peri-menopausal 1, 3
  • Fair-skinned individuals are most commonly affected 3
  • Classic anatomic distribution: lateral neck, upper chest (V-area), and face, with characteristic sparing of the submental and submandibular regions (the shaded areas under the chin) 1, 4

Primary Clinical Features

Vascular Component

  • Telangiectasias are a defining feature, appearing as dilated fine blood vessels on the affected skin 3, 2
  • Dermoscopically, these manifest as converging curved vessels (64.3% of cases), linear irregular vessels (60.7%), and rhomboidal/polygonal vessels (53.6%) 1
  • Combination of linear and dotted vessels observed in 28.6% of cases 1

Pigmentary Changes

  • Mottled appearance with both hyperpigmentation and hypopigmentation occurring simultaneously 3, 2
  • Brown macules present in 39.3% of cases on dermoscopy 1
  • White macules observed in 82.1% of cases, representing areas of hypopigmentation 1

Atrophic Changes

  • Cutaneous atrophy is the third component of the classic triad 5, 2
  • Whitish follicular plugs may be visible on dermoscopic examination (21.4% of cases) 1

Dermoscopic Patterns

When examined with dermoscopy, Poikiloderma of Civatte demonstrates highly characteristic patterns that aid in diagnosis:

  • Reticular pattern is most common (53.6% of cases) 1
  • White dots appear in 35.7% of cases 1
  • Non-specific patterns in 32.1% 1
  • The dermoscopic picture corresponds well with both clinical presentation and histological findings 1

Key Distinguishing Features

The pathognomonic feature is the sharp demarcation with sparing of the shaded submental area, which helps differentiate this from other poikilodermas with more serious prognoses 1, 4. This sparing pattern strongly suggests chronic photodamage as the underlying mechanism, distinguishing it from systemic causes of poikiloderma.

Clinical Pitfall

Do not confuse Poikiloderma of Civatte with poikiloderma associated with genetic syndromes (such as Rothmund-Thomson syndrome or Bloom syndrome) or dermatomyositis, which have different distributions, age of onset (often infantile in genetic syndromes), and carry significantly different prognostic implications including malignancy risk 6, 7. The benign nature of Poikiloderma of Civatte, its characteristic anatomic distribution with submental sparing, and its onset in middle age clearly differentiate it from these conditions.

References

Research

Acquired poikiloderma: proposed classification and diagnostic approach.

Journal of the American Academy of Dermatology, 2013

Research

Fractional photothermolysis for treatment of poikiloderma of civatte.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2006

Research

Treatment of poikiloderma of Civatte with an intense pulsed light source.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Poichilodermia: Caratteristiche, Cause e Gestione

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.